ArticleBritish journal of pharmacology2020

Roflupram exerts neuroprotection via activation of CREB/PGC-1α signalling in experimental models of Parkinson's disease.

Jiahong Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.